Show
Sort by
-
- Journal Article
- A1
- open access
Global variation in magnetic resonance imaging quality of the prostate
-
Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer : a systematic literature review
-
A systematic review on the role of imaging in early recurrent prostate cancer
-
Practice patterns compared with evidence-based strategies for the management of androgen deprivation therapy-induced side effects in prostate cancer patients : results of a European web-based survey
-
- Journal Article
- A2
- open access
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer
-
Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature
-
Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging?: a systematic review of the literature
-
The oncologic role of local treatment in primary metastatic prostate cancer
-
Prognostic effect of neuroendocrine differentiation in prostate cancer : a critical review
-
Systematic ultrasound-guided saturation and template biopsy of the prostate : indications and advantages of extended sampling
-
Management of node only recurrence after primary local treatment for prostate cancer : a systematic review of the literature
-
- Journal Article
- A1
- open access
Preferences in management of high-risk prostate cancer among urologists in Europe: results of a web-based survey
-
Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey
(2015) -
Can we expand active surveillance criteria to include biopsy Gleason 3 + 4 prostate cancer? A multi-institutional study of 2,323 patients
-
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series
-
Clinical perspectives from randomized phase 3 trials on prostate cancer : an analysis of the ClinicalTrials.gov database
-
Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058–66